TheraRadar
← Back
Data updated: Mar 29, 2026

MARSAM PHARMS LLC

DermatologyCardiovascular
Generics

MARSAM PHARMS LLC is a generic drug manufacturer focused on Dermatology, Cardiovascular.

1987
Since
13
Drugs
-
Trials
145
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

CHLORPROMAZINE HYDROCHLORIDE 2026-01-26
FUROSEMIDE 2026-01-08
HALOPERIDOL 2025-12-18
VERAPAMIL HYDROCHLORIDE 2025-11-24
DIAZEPAM 2025-11-14
VERAPAMIL HYDROCHLORIDE 2025-11-13
CHLORPROMAZINE HYDROCHLORIDE 2025-10-10
VERAPAMIL HYDROCHLORIDE 2025-09-19
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 50%
1 drugs
Cardiovascular 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Baxter specialty
Cardiovascular, Dermatology
Bayer big-pharma
Cardiovascular, Dermatology
B BRAUN specialty
Dermatology, Cardiovascular
BAUSCH specialty
Dermatology, Cardiovascular
COSETTE other
Cardiovascular, Dermatology